No abstract available
MeSH terms
-
Antibodies, Monoclonal / economics
-
Antibodies, Monoclonal / therapeutic use
-
Arthritis, Rheumatoid / economics*
-
Arthritis, Rheumatoid / immunology
-
Arthritis, Rheumatoid / therapy
-
Cost-Benefit Analysis
-
Cytokines / economics
-
Cytokines / therapeutic use
-
Decision Making
-
Drug Costs*
-
Health Services Accessibility
-
Humans
-
Infliximab
-
Insurance Coverage
-
Patient Selection
-
Tumor Necrosis Factor-alpha / antagonists & inhibitors*
-
United States
Substances
-
Antibodies, Monoclonal
-
Cytokines
-
Tumor Necrosis Factor-alpha
-
Infliximab